[Surgical treatment of primary tumors of the heart]

Insights

Surgical treatment of heart tumors in 34 patients showed low mortality for benign tumors, with no recurrences. Malignant tumors had a poorer prognosis, highlighting the need for advanced surgical techniques.

Area of Science:

  • Cardiovascular Surgery
  • Surgical Oncology

Background:

  • Heart tumors are rare but can be life-threatening.
  • Surgical intervention is the primary treatment modality.

Purpose of the Study:

  • To review surgical outcomes for heart tumors.
  • To evaluate the efficacy of surgical treatment for benign and malignant cardiac neoplasms.

Main Methods:

  • Retrospective analysis of 34 patients with heart tumors.
  • Surgical procedures performed under extracorporeal circulation.
  • Inclusion of various benign and malignant tumor types.

Main Results:

  • Twenty-five patients with benign tumors (myxomas, leiomyomas, fibromas, etc.) had 4% mortality and no recurrences.
  • Successful tumor removal in 3 of 9 patients with malignant tumors, including complex reconstructions.
  • Long-term follow-up data limited for malignant tumor cases.

Conclusions:

  • Surgical treatment of benign heart tumors yields excellent long-term results.
  • Malignant heart tumors present significant surgical challenges with guarded prognoses.
  • Further research is needed to improve outcomes for malignant cardiac tumors.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...